Skip to main content

May 2016, Vol 6, No 5

Over the past several years, physician office–based infusion services have been migrating to the hospital outpatient setting. The 2 main reasons for this shift can be seen as (1) financial pressures that have made the private practice model increasingly difficult to sustain, and (2) hospitals generally enjoy better payment terms than private practices, and therefore generate higher margins, particularly for hospitals with access to the 340B drug pricing program. Read More ›

The sharply worded scuffle over the recent Centers for Medicare & Medicaid Services (CMS)’s proposed rule about Medicare Part B payments showcases some of the strong opposing forces at play in the increasingly costly US healthcare system, and the reason why it has been almost impossible to arrive at effective changes. Read More ›

The details are still being debated, but the following are 2 well-known facts about the physician reimbursement models of the future. Read More ›

The noise around drug costs has gotten louder in recent months: policymakers clamoring for controls on drug pricing, congressional hearings calling on pharmaceutical executives to testify, and recommendations from the Medicare Payment Advisory Commission (MedPAC) focused on containing Medicare spending in the context of ever-increasing prescription drug costs. Read More ›

In March 2016, nearly 500 oncology professionals gathered in Washington, DC, for the 42nd ACCC Annual Meeting, CANCERSCAPE. Throughout sessions centered on policy, value, and quality, attendees heard a recurrent message: your experience, perspective, and input on the issues of value-based care, quality measures, and outcomes are essential as the healthcare system and oncol­ogy transition to the new world of alternative payment models and value-based care. Read More ›

Aggregated real-time data provide the tools to rapidly identify opportunities for the improvement of delivered services and for the initiation of quality improvement projects. Enhanced information technology capabilities, such as the iRiS software app, are foundational for practice transformation to future value-based cancer care models, according to John D. Sprandio, Sr, MD, Chief Physician, Consultants in Medical Oncology and Hematology (CMOH), Drexel Hill, PA. Read More ›

Page 1 of 2